India approves Russian Covid-19 vaccine Sputnik V for emergency use


Amid the surging Covid-19 cases and demand to vaccinate more people, the expert panel of country’s drug regulator approved the emergency use of Russia’s Sputnik V Covid-19 vaccine, according to media reports.

This will be the third vaccine to be available in the country after Covishield and Covaxin.

Around 10 crore doses of the vaccine (Sputnik V) is likely to be imported for emergency use in the country in the next six months, Indian Express newspaper said quoting sources.

Sputnik V has demonstrated an efficacy rate of 91.6 per cent in the interim analysis of phase 3 clinical trial, which included data on 19,866 volunteers in Russia, the newspaper said.

The cumulative number of Covid-19 vaccine doses administered in the country stands at 10.82 crore as per the 8 pm provisional report on April 12.

On an average 45,000 COVID Vaccination Centres (CVCs) are functional on any given day.

In terms of the number of daily doses administered globally, India continues to remain at the top with an average of 40,55,055 doses administered per day.

India’s daily new cases continue to rise. 1,68,912 new cases were registered in the last 24 hours.

Ten States including Maharashtra, Uttar Pradesh, Delhi, Chhattisgarh, Karnataka, Kerala, Tamil Nadu, Madhya Pradesh, Gujarat and Rajasthan have shown a rise in the Covid-19 daily new cases. About 83% of the new cases are reported from these 10 states.